Daniel Gesua Sive Salvadori, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 50,355 shares at $54.90 ($2.8M) on 2017-12-14, disclosed to the SEC on 2017-12-14.
Open-market sale of $2.8M ABT by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.90 | 9,839 | $540K | 19.5% |
| 2 | $54.90 | 9,839 | $540K | 19.5% |
| 3 | $54.91 | 1,483 | $81K | 2.9% |
| 4 | $54.93 | 6,897 | $379K | 13.7% |
| 5 | $54.93 | 6,897 | $379K | 13.7% |
| 6 | $54.94 | 7,700 |
| $423K |
| 15.3% |
| 7 | $54.94 | 7,700 | $423K | 15.3% |
| Total | $54.92 avg | 50,355 | $2.8M | 100% |
| Filing → |
| ABT | SELL | 2024-03-04 | $228K | — | Filing → |
| ABT | SELL | 2023-03-02 | $219K | — | Filing → |
| ABT | SELL | 2022-03-02 | $366K | — | Filing → |